Effect of teriparatide (rh-PTH 1–34) versus bisphosphonate on the healing of osteoporotic vertebral compression fracture: A retrospective comparative study

BACKGROUND: Teriparatide (recombinant human parathyroid hormone 1–34) is increasingly used for the treatment of severe osteoporosis because it stimulates bone formation and may potentially enhance fracture healing. The objective of this study was to investigate the effects of teriparatide versus a b...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwata, Akira, Kanayama, Masahiro, Oha, Fumihiro, Hashimoto, Tomoyuki, Iwasaki, Norimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384154/
https://www.ncbi.nlm.nih.gov/pubmed/28388910
http://dx.doi.org/10.1186/s12891-017-1509-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384154/
https://www.ncbi.nlm.nih.gov/pubmed/28388910
http://dx.doi.org/10.1186/s12891-017-1509-1

Ejemplares similares